25 XP   0   0   10

Tibet Cheezheng Tibetan Medicine Co Ltd
Buy, Hold or Sell?

Let's analyse Cheezheng together

PenkeI guess you are interested in Tibet Cheezheng Tibetan Medicine Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tibet Cheezheng Tibetan Medicine Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tibet Cheezheng Tibetan Medicine Co Ltd

I send you an email if I find something interesting about Tibet Cheezheng Tibetan Medicine Co Ltd.

Quick analysis of Cheezheng (30 sec.)










What can you expect buying and holding a share of Cheezheng? (30 sec.)

How much money do you get?

How much money do you get?
¥0.36
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.39
Expected worth in 1 year
¥7.65
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥3.83
Return On Investment
17.9%

For what price can you sell your share?

Current Price per Share
¥21.36
Expected price per share
¥16.27 - ¥22.93
How sure are you?
50%

1. Valuation of Cheezheng (5 min.)




Live pricePrice per Share (EOD)

¥21.36

Intrinsic Value Per Share

¥-4.49 - ¥4.17

Total Value Per Share

¥1.90 - ¥10.56

2. Growth of Cheezheng (5 min.)




Is Cheezheng growing?

Current yearPrevious yearGrowGrow %
How rich?$468.1m$445m$23.1m4.9%

How much money is Cheezheng making?

Current yearPrevious yearGrowGrow %
Making money$65.2m$98.9m-$33.6m-51.5%
Net Profit Margin23.1%40.4%--

How much money comes from the company's main activities?

3. Financial Health of Cheezheng (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#116 / 1016

Most Revenue
#51 / 1016

Most Profit
#38 / 1016

Most Efficient
#68 / 1016

What can you expect buying and holding a share of Cheezheng? (5 min.)

Welcome investor! Cheezheng's management wants to use your money to grow the business. In return you get a share of Cheezheng.

What can you expect buying and holding a share of Cheezheng?

First you should know what it really means to hold a share of Cheezheng. And how you can make/lose money.

Speculation

The Price per Share of Cheezheng is ¥21.36. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cheezheng.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cheezheng, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.39. Based on the TTM, the Book Value Change Per Share is ¥0.32 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.64 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cheezheng.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.120.6%0.120.6%0.190.9%0.120.6%0.090.4%
Usd Book Value Change Per Share0.040.2%0.040.2%0.150.7%0.080.4%0.050.2%
Usd Dividend Per Share0.090.4%0.090.4%0.050.2%0.060.3%0.050.2%
Usd Total Gains Per Share0.130.6%0.130.6%0.201.0%0.130.6%0.100.5%
Usd Price Per Share3.16-3.16-4.22-3.49-4.01-
Price to Earnings Ratio25.65-25.65-22.64-31.13-48.37-
Price-to-Total Gains Ratio23.84-23.84-20.73-27.92-47.15-
Price to Book Ratio3.58-3.58-5.03-5.08-7.73-
Price-to-Total Gains Ratio23.84-23.84-20.73-27.92-47.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.951952
Number of shares338
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.090.06
Usd Book Value Change Per Share0.040.08
Usd Total Gains Per Share0.130.13
Gains per Quarter (338 shares)44.7745.20
Gains per Year (338 shares)179.09180.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11205916976105171
2240118348151211352
3360177527227316533
4480236706302421714
5600296885378526895
672035510644536321076
784041412435297371257
896047314226048421438
9108053216016809471619
101200591178075510531800

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.02.086.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%

Fundamentals of Cheezheng

About Tibet Cheezheng Tibetan Medicine Co Ltd

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. It provides products in the areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-14 14:39:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Tibet Cheezheng Tibetan Medicine Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cheezheng earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Cheezheng to the Biotechnology industry mean.
  • A Net Profit Margin of 23.1% means that ¥0.23 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 23.1%. The company is making a huge profit. +2
  • The TTM is 23.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.1%TTM23.1%0.0%
TTM23.1%YOY40.4%-17.3%
TTM23.1%5Y28.7%-5.5%
5Y28.7%10Y27.5%+1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.1%-197.2%+220.3%
TTM23.1%-210.4%+233.5%
YOY40.4%-279.3%+319.7%
5Y28.7%-436.8%+465.5%
10Y27.5%-599.3%+626.8%
1.1.2. Return on Assets

Shows how efficient Cheezheng is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cheezheng to the Biotechnology industry mean.
  • 8.0% Return on Assets means that Cheezheng generated ¥0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 8.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.0%TTM8.0%0.0%
TTM8.0%YOY12.9%-4.8%
TTM8.0%5Y11.2%-3.2%
5Y11.2%10Y12.3%-1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0%-13.6%+21.6%
TTM8.0%-12.9%+20.9%
YOY12.9%-11.9%+24.8%
5Y11.2%-14.2%+25.4%
10Y12.3%-16.2%+28.5%
1.1.3. Return on Equity

Shows how efficient Cheezheng is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cheezheng to the Biotechnology industry mean.
  • 14.2% Return on Equity means Cheezheng generated ¥0.14 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 14.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.2%TTM14.2%0.0%
TTM14.2%YOY22.6%-8.4%
TTM14.2%5Y16.8%-2.7%
5Y16.8%10Y16.4%+0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.2%-17.0%+31.2%
TTM14.2%-16.1%+30.3%
YOY22.6%-15.4%+38.0%
5Y16.8%-20.0%+36.8%
10Y16.4%-21.1%+37.5%

1.2. Operating Efficiency of Tibet Cheezheng Tibetan Medicine Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cheezheng is operating .

  • Measures how much profit Cheezheng makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cheezheng to the Biotechnology industry mean.
  • An Operating Margin of 25.8% means the company generated ¥0.26  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 25.8%. The company is operating very efficient. +2
  • The TTM is 25.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ25.8%TTM25.8%0.0%
TTM25.8%YOY28.1%-2.3%
TTM25.8%5Y25.4%+0.4%
5Y25.4%10Y21.6%+3.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ25.8%-286.1%+311.9%
TTM25.8%-224.4%+250.2%
YOY28.1%-288.4%+316.5%
5Y25.4%-475.2%+500.6%
10Y21.6%-624.7%+646.3%
1.2.2. Operating Ratio

Measures how efficient Cheezheng is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are ¥0.86 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 0.864. The company is less efficient in keeping operating costs low.
  • The TTM is 0.864. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.864TTM0.8640.000
TTM0.864YOY0.869-0.004
TTM0.8645Y0.862+0.002
5Y0.86210Y0.758+0.104
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8642.997-2.133
TTM0.8643.247-2.383
YOY0.8693.766-2.897
5Y0.8625.675-4.813
10Y0.7587.857-7.099

1.3. Liquidity of Tibet Cheezheng Tibetan Medicine Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cheezheng is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.35 means the company has ¥2.35 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 2.347. The company is able to pay all its short-term debts. +1
  • The TTM is 2.347. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.347TTM2.3470.000
TTM2.347YOY2.245+0.102
TTM2.3475Y3.821-1.474
5Y3.82110Y3.297+0.524
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3473.930-1.583
TTM2.3474.251-1.904
YOY2.2455.436-3.191
5Y3.8216.045-2.224
10Y3.2976.363-3.066
1.3.2. Quick Ratio

Measures if Cheezheng is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cheezheng to the Biotechnology industry mean.
  • A Quick Ratio of 1.21 means the company can pay off ¥1.21 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 1.207. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.207. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.207TTM1.2070.000
TTM1.207YOY1.376-0.169
TTM1.2075Y1.732-0.525
5Y1.73210Y3.600-1.868
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2073.629-2.422
TTM1.2074.065-2.858
YOY1.3765.397-4.021
5Y1.7325.993-4.261
10Y3.6006.277-2.677

1.4. Solvency of Tibet Cheezheng Tibetan Medicine Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cheezheng assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cheezheng to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.42 means that Cheezheng assets are financed with 42.5% credit (debt) and the remaining percentage (100% - 42.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 0.425. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.425. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.425TTM0.4250.000
TTM0.425YOY0.422+0.003
TTM0.4255Y0.323+0.102
5Y0.32310Y0.234+0.089
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4250.332+0.093
TTM0.4250.334+0.091
YOY0.4220.268+0.154
5Y0.3230.366-0.043
10Y0.2340.390-0.156
1.4.2. Debt to Equity Ratio

Measures if Cheezheng is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cheezheng to the Biotechnology industry mean.
  • A Debt to Equity ratio of 74.9% means that company has ¥0.75 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The MRQ is 0.749. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.749. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.749TTM0.7490.000
TTM0.749YOY0.741+0.008
TTM0.7495Y0.528+0.221
5Y0.52810Y0.352+0.176
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7490.381+0.368
TTM0.7490.390+0.359
YOY0.7410.334+0.407
5Y0.5280.434+0.094
10Y0.3520.466-0.114

2. Market Valuation of Tibet Cheezheng Tibetan Medicine Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Cheezheng generates.

  • Above 15 is considered overpriced but always compare Cheezheng to the Biotechnology industry mean.
  • A PE ratio of 25.65 means the investor is paying ¥25.65 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The EOD is 23.974. Based on the earnings, the company is fair priced.
  • The MRQ is 25.646. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.646. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD23.974MRQ25.646-1.672
MRQ25.646TTM25.6460.000
TTM25.646YOY22.638+3.009
TTM25.6465Y31.125-5.479
5Y31.12510Y48.366-17.241
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD23.974-2.315+26.289
MRQ25.646-2.560+28.206
TTM25.646-2.664+28.310
YOY22.638-4.122+26.760
5Y31.125-6.258+37.383
10Y48.366-6.108+54.474
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The EOD is 852.248. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 911.698. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 911.698. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD852.248MRQ911.698-59.450
MRQ911.698TTM911.6980.000
TTM911.698YOY17.821+893.877
TTM911.6985Y172.176+739.522
5Y172.17610Y134.178+37.998
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD852.248-3.067+855.315
MRQ911.698-3.251+914.949
TTM911.698-3.545+915.243
YOY17.821-5.595+23.416
5Y172.176-8.315+180.491
10Y134.178-8.708+142.886
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cheezheng is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.58 means the investor is paying ¥3.58 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Tibet Cheezheng Tibetan Medicine Co Ltd:

  • The EOD is 3.343. Based on the equity, the company is fair priced.
  • The MRQ is 3.576. Based on the equity, the company is fair priced.
  • The TTM is 3.576. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.343MRQ3.576-0.233
MRQ3.576TTM3.5760.000
TTM3.576YOY5.032-1.456
TTM3.5765Y5.083-1.507
5Y5.08310Y7.730-2.646
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.3431.905+1.438
MRQ3.5762.111+1.465
TTM3.5762.095+1.481
YOY5.0322.836+2.196
5Y5.0833.443+1.640
10Y7.7303.794+3.936
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tibet Cheezheng Tibetan Medicine Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3160.3160%1.105-71%0.563-44%0.384-18%
Book Value Per Share--6.3896.3890%6.073+5%5.111+25%4.120+55%
Current Ratio--2.3472.3470%2.245+5%3.821-39%3.297-29%
Debt To Asset Ratio--0.4250.4250%0.422+1%0.323+32%0.234+82%
Debt To Equity Ratio--0.7490.7490%0.741+1%0.528+42%0.352+113%
Dividend Per Share--0.6420.6420%0.369+74%0.404+59%0.345+86%
Eps--0.8910.8910%1.350-34%0.858+4%0.676+32%
Free Cash Flow Per Share--0.0250.0250%1.715-99%0.583-96%0.465-95%
Free Cash Flow To Equity Per Share---0.320-0.3200%1.634-120%0.778-141%0.487-166%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.175--------
Intrinsic Value_10Y_min---4.487--------
Intrinsic Value_1Y_max--0.549--------
Intrinsic Value_1Y_min--0.237--------
Intrinsic Value_3Y_max--1.550--------
Intrinsic Value_3Y_min--0.121--------
Intrinsic Value_5Y_max--2.431--------
Intrinsic Value_5Y_min---0.640--------
Market Cap11324495109.120-7%12115612916.00012115612916.0000%16205861651.200-25%13376046658.146-9%15379149186.929-21%
Net Profit Margin--0.2310.2310%0.404-43%0.287-19%0.275-16%
Operating Margin--0.2580.2580%0.281-8%0.254+2%0.216+20%
Operating Ratio--0.8640.8640%0.869-1%0.862+0%0.758+14%
Pb Ratio3.343-7%3.5763.5760%5.032-29%5.083-30%7.730-54%
Pe Ratio23.974-7%25.64625.6460%22.638+13%31.125-18%48.366-47%
Price Per Share21.360-7%22.85022.8500%30.560-25%25.226-9%29.006-21%
Price To Free Cash Flow Ratio852.248-7%911.698911.6980%17.821+5016%172.176+430%134.178+579%
Price To Total Gains Ratio22.285-7%23.83923.8390%20.735+15%27.917-15%47.146-49%
Quick Ratio--1.2071.2070%1.376-12%1.732-30%3.600-66%
Return On Assets--0.0800.0800%0.129-38%0.112-28%0.123-35%
Return On Equity--0.1420.1420%0.226-37%0.168-16%0.164-14%
Total Gains Per Share--0.9590.9590%1.474-35%0.968-1%0.729+32%
Usd Book Value--468173787.601468173787.6010%445056878.613+5%374515903.245+25%301882843.529+55%
Usd Book Value Change Per Share--0.0440.0440%0.153-71%0.078-44%0.053-18%
Usd Book Value Per Share--0.8830.8830%0.839+5%0.706+25%0.569+55%
Usd Dividend Per Share--0.0890.0890%0.051+74%0.056+59%0.048+86%
Usd Eps--0.1230.1230%0.187-34%0.119+4%0.093+32%
Usd Free Cash Flow--1836548.4461836548.4460%125671536.133-99%42743916.668-96%34079554.376-95%
Usd Free Cash Flow Per Share--0.0030.0030%0.237-99%0.081-96%0.064-95%
Usd Free Cash Flow To Equity Per Share---0.044-0.0440%0.226-120%0.108-141%0.067-166%
Usd Market Cap1565045224.080-7%1674377704.9911674377704.9910%2239650080.196-25%1848569648.156-9%2125398417.634-21%
Usd Price Per Share2.952-7%3.1583.1580%4.223-25%3.486-9%4.009-21%
Usd Profit--65286817.28465286817.2840%98934091.043-34%62936454.204+4%49524362.087+32%
Usd Revenue--282589886.817282589886.8170%244681163.779+15%218559847.830+29%177478565.157+59%
Usd Total Gains Per Share--0.1320.1320%0.204-35%0.134-1%0.101+32%
 EOD+4 -4MRQTTM+0 -0YOY+11 -245Y+13 -2210Y+15 -20

3.2. Fundamental Score

Let's check the fundamental score of Tibet Cheezheng Tibetan Medicine Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1523.974
Price to Book Ratio (EOD)Between0-13.343
Net Profit Margin (MRQ)Greater than00.231
Operating Margin (MRQ)Greater than00.258
Quick Ratio (MRQ)Greater than11.207
Current Ratio (MRQ)Greater than12.347
Debt to Asset Ratio (MRQ)Less than10.425
Debt to Equity Ratio (MRQ)Less than10.749
Return on Equity (MRQ)Greater than0.150.142
Return on Assets (MRQ)Greater than0.050.080
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Tibet Cheezheng Tibetan Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.832
Ma 20Greater thanMa 5021.517
Ma 50Greater thanMa 10020.913
Ma 100Greater thanMa 20021.632
OpenGreater thanClose21.420
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets5,886,644
Total Liabilities2,498,990
Total Stockholder Equity3,336,014
 As reported
Total Liabilities 2,498,990
Total Stockholder Equity+ 3,336,014
Total Assets = 5,886,644

Assets

Total Assets5,886,644
Total Current Assets3,192,415
Long-term Assets2,694,229
Total Current Assets
Cash And Cash Equivalents 437,571
Short-term Investments 1,539,290
Net Receivables 102,418
Inventory 127,774
Other Current Assets 27,699
Total Current Assets  (as reported)3,192,415
Total Current Assets  (calculated)2,234,753
+/- 957,662
Long-term Assets
Property Plant Equipment 1,144,427
Intangible Assets 374,807
Other Assets 58,761
Long-term Assets  (as reported)2,694,229
Long-term Assets  (calculated)1,577,995
+/- 1,116,234

Liabilities & Shareholders' Equity

Total Current Liabilities1,360,129
Long-term Liabilities1,138,861
Total Stockholder Equity3,336,014
Total Current Liabilities
Short Long Term Debt 701,726
Accounts payable 93,472
Other Current Liabilities 173,651
Total Current Liabilities  (as reported)1,360,129
Total Current Liabilities  (calculated)968,849
+/- 391,280
Long-term Liabilities
Long term Debt 929,469
Capital Lease Obligations Min Short Term Debt4,912
Other Liabilities 204,480
Long-term Liabilities  (as reported)1,138,861
Long-term Liabilities  (calculated)1,138,861
+/- 0
Total Stockholder Equity
Common Stock530,224
Retained Earnings 2,201,747
Other Stockholders Equity 158,091
Total Stockholder Equity (as reported)3,336,014
Total Stockholder Equity (calculated)2,890,061
+/- 445,953
Other
Capital Stock530,224
Common Stock Shares Outstanding 530,224
Net Debt 1,193,624
Net Invested Capital 4,967,209
Net Tangible Assets 2,961,207
Net Working Capital 1,832,286
Property Plant and Equipment Gross 1,144,427



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
631,303
1,297,342
1,320,037
1,357,548
1,432,556
1,534,557
1,791,887
2,070,132
2,075,693
2,296,568
2,312,773
2,984,122
4,459,100
5,567,754
5,886,644
5,886,6445,567,7544,459,1002,984,1222,312,7732,296,5682,075,6932,070,1321,791,8871,534,5571,432,5561,357,5481,320,0371,297,342631,303
   > Total Current Assets 
0
0
0
0
0
0
0
1,389,080
1,391,074
1,558,697
1,488,871
2,135,368
2,972,467
2,936,398
3,192,415
3,192,4152,936,3982,972,4672,135,3681,488,8711,558,6971,391,0741,389,0800000000
       Cash And Cash Equivalents 
214,947
826,966
761,110
521,131
515,474
524,986
283,873
352,439
457,928
386,433
395,512
1,346,751
1,829,900
666,634
437,571
437,571666,6341,829,9001,346,751395,512386,433457,928352,439283,873524,986515,474521,131761,110826,966214,947
       Short-term Investments 
0
0
0
0
0
0
337,000
270,000
200,000
421,000
440,000
32,279
0
1,183,970
1,539,290
1,539,2901,183,970032,279440,000421,000200,000270,000337,000000000
       Net Receivables 
256,563
279,094
284,826
394,626
455,283
504,858
582,364
665,745
646,099
689,335
562,872
688,622
12,616
616,220
102,418
102,418616,22012,616688,622562,872689,335646,099665,745582,364504,858455,283394,626284,826279,094256,563
       Other Current Assets 
1,859
20,856
40,581
35,091
46,669
34,333
63,223
34,952
39,979
7,308
17,870
4,403
9,683
39,877
27,699
27,69939,8779,6834,40317,8707,30839,97934,95263,22334,33346,66935,09140,58120,8561,859
   > Long-term Assets 
0
0
0
0
0
0
0
0
684,620
737,871
823,902
848,755
1,488,563
2,631,356
2,694,229
2,694,2292,631,3561,488,563848,755823,902737,871684,62000000000
       Property Plant Equipment 
101,524
116,632
149,196
228,787
253,470
319,776
292,374
347,622
322,877
404,196
488,376
545,722
577,811
821,350
1,144,427
1,144,427821,350577,811545,722488,376404,196322,877347,622292,374319,776253,470228,787149,196116,632101,524
       Long Term Investments 
0
0
0
0
0
0
0
237,500
237,500
240,000
225,149
0
0
0
0
0000225,149240,000237,500237,5000000000
       Intangible Assets 
24,352
2,402
2,008
3,124
2,949
2,245
85,290
84,848
50,757
49,298
47,687
45,746
176,203
399,326
374,807
374,807399,326176,20345,74647,68749,29850,75784,84885,2902,2452,9493,1242,0082,40224,352
       Long-term Assets Other 
0
0
0
0
0
0
0
0
67,663
16,700
41,603
8,904
470,967
219,975
3,912
3,912219,975470,9678,90441,60316,70067,66300000000
> Total Liabilities 
99,024
152,679
110,718
80,010
80,898
86,344
242,204
419,050
324,333
402,776
267,539
722,200
1,824,514
2,347,371
2,498,990
2,498,9902,347,3711,824,514722,200267,539402,776324,333419,050242,20486,34480,89880,010110,718152,67999,024
   > Total Current Liabilities 
91,142
140,680
102,253
71,204
60,316
39,227
173,527
347,587
263,016
340,180
202,277
654,130
764,444
1,307,979
1,360,129
1,360,1291,307,979764,444654,130202,277340,180263,016347,587173,52739,22760,31671,204102,253140,68091,142
       Short-term Debt 
0
0
0
0
0
0
0
0
116,496
220,000
0
0
0
0
0
00000220,000116,49600000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
116,496
220,000
0
300,188
300,160
501,809
701,726
701,726501,809300,160300,1880220,000116,49600000000
       Accounts payable 
3,434
6,152
6,437
7,877
5,357
8,066
19,315
34,837
6,388
9,196
4,608
20,192
52,213
184,003
93,472
93,472184,00352,21320,1924,6089,1966,38834,83719,3158,0665,3577,8776,4376,1523,434
       Other Current Liabilities 
84,494
134,528
95,816
63,327
54,959
31,161
154,211
40,071
32,062
45,219
51,816
99,873
151,402
378,497
173,651
173,651378,497151,40299,87351,81645,21932,06240,071154,21131,16154,95963,32795,816134,52884,494
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
61,317
62,596
65,262
68,070
1,062,551
1,039,392
1,138,861
1,138,8611,039,3921,062,55168,07065,26262,59661,31700000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-116,496
-220,000
0
0
10,012
4,936
4,912
4,9124,93610,01200-220,000-116,49600000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
61,317
0
0
0
0
0
0
00000061,31700000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
1,911
1,734
1,563
134
80
150
5,250
0
05,250150801341,5631,7341,9110000000
> Total Stockholder Equity
531,082
1,143,094
1,187,695
1,244,734
1,321,233
1,408,746
1,504,180
1,611,077
1,734,478
1,876,981
2,029,288
2,245,540
2,618,152
3,169,031
3,336,014
3,336,0143,169,0312,618,1522,245,5402,029,2881,876,9811,734,4781,611,0771,504,1801,408,7461,321,2331,244,7341,187,6951,143,094531,082
   Common Stock
365,000
406,000
406,000
406,000
406,000
406,000
406,000
406,000
406,000
406,000
406,000
530,181
530,345
530,297
530,224
530,224530,297530,345530,181406,000406,000406,000406,000406,000406,000406,000406,000406,000406,000365,000
   Retained Earnings 
148,997
294,657
323,873
368,362
427,909
493,478
687,158
794,135
917,537
1,060,039
1,212,346
1,288,355
1,506,365
2,042,121
2,201,747
2,201,7472,042,1211,506,3651,288,3551,212,3461,060,039917,537794,135687,158493,478427,909368,362323,873294,657148,997
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
1,232
133,335
149,239
158,091
158,091149,239133,3351,23200000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,874,894
Cost of Revenue-309,120
Gross Profit1,565,7741,565,774
 
Operating Income (+$)
Gross Profit1,565,774
Operating Expense-1,390,869
Operating Income484,025174,905
 
Operating Expense (+$)
Research Development48,334
Selling General Administrative951,731
Selling And Marketing Expenses-
Operating Expense1,390,8691,000,065
 
Net Interest Income (+$)
Interest Income21,658
Interest Expense-58,837
Other Finance Cost-9,755
Net Interest Income-46,935
 
Pretax Income (+$)
Operating Income484,025
Net Interest Income-46,935
Other Non-Operating Income Expenses-
Income Before Tax (EBT)543,149484,025
EBIT - interestExpense = -58,837
493,370
552,207
Interest Expense58,837
Earnings Before Interest and Taxes (EBIT)-601,987
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax543,149
Tax Provision-51,625
Net Income From Continuing Ops491,524491,524
Net Income493,370
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-46,935
 

Technical Analysis of Cheezheng
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cheezheng. The general trend of Cheezheng is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cheezheng's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tibet Cheezheng Tibetan Medicine Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 22.08 < 22.37 < 22.93.

The bearish price targets are: 20.70 > 16.27.

Tweet this
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tibet Cheezheng Tibetan Medicine Co Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tibet Cheezheng Tibetan Medicine Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tibet Cheezheng Tibetan Medicine Co Ltd. The current macd is -0.02024969.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cheezheng price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cheezheng. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cheezheng price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tibet Cheezheng Tibetan Medicine Co Ltd. The current adx is 14.47.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cheezheng shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tibet Cheezheng Tibetan Medicine Co Ltd. The current sar is 21.81.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tibet Cheezheng Tibetan Medicine Co Ltd. The current rsi is 49.83. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Relative Strength Index (RSI) ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tibet Cheezheng Tibetan Medicine Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cheezheng price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Stochastic Oscillator ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tibet Cheezheng Tibetan Medicine Co Ltd. The current cci is -27.55110994.

Tibet Cheezheng Tibetan Medicine Co Ltd Daily Commodity Channel Index (CCI) ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tibet Cheezheng Tibetan Medicine Co Ltd. The current cmo is -1.35100758.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tibet Cheezheng Tibetan Medicine Co Ltd. The current willr is -50.70422535.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cheezheng is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Williams %R ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tibet Cheezheng Tibetan Medicine Co Ltd.

Tibet Cheezheng Tibetan Medicine Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tibet Cheezheng Tibetan Medicine Co Ltd. The current atr is 0.56298562.

Tibet Cheezheng Tibetan Medicine Co Ltd Daily Average True Range (ATR) ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tibet Cheezheng Tibetan Medicine Co Ltd. The current obv is 53,783,731.

Tibet Cheezheng Tibetan Medicine Co Ltd Daily On-Balance Volume (OBV) ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tibet Cheezheng Tibetan Medicine Co Ltd. The current mfi is 47.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tibet Cheezheng Tibetan Medicine Co Ltd Daily Money Flow Index (MFI) ChartTibet Cheezheng Tibetan Medicine Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tibet Cheezheng Tibetan Medicine Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Tibet Cheezheng Tibetan Medicine Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tibet Cheezheng Tibetan Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.832
Ma 20Greater thanMa 5021.517
Ma 50Greater thanMa 10020.913
Ma 100Greater thanMa 20021.632
OpenGreater thanClose21.420
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cheezheng with someone you think should read this too:
  • Are you bullish or bearish on Cheezheng? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cheezheng? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tibet Cheezheng Tibetan Medicine Co Ltd

I send you an email if I find something interesting about Tibet Cheezheng Tibetan Medicine Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tibet Cheezheng Tibetan Medicine Co Ltd.

Receive notifications about Tibet Cheezheng Tibetan Medicine Co Ltd in your mailbox!